Percutaneous Ethanol Sclerotherapy of Symptomatic Nodules Is Effective and Safe in Pregnant Women: A Study of 13 Patients with an Average Follow-Up of 6.8 Years
Table 1
Pretreatment clinical data on patients.
Age (ys)
Gestational week at 1st session
Degree of compression1
Size of nodule (mL)
Aspirated cystic fluid (mL)
Number of sessions
TSH (mIU/L)
FT4 (pM/L)
Type of nodule
Nontoxic, cystic
22
16
2
17.9
9
3
1.01
13.9
Nontoxic, cystic
25
19
3
24.9
14
3
0.87
14.6
Nontoxic, cystic
29
16
3
30.6
24
3
3.01
12.7
Nontoxic, cystic
34
17
2
8.6
6.5
2
0.33
15.1
Nontoxic, cystic
39
18
3
11.9
5.7
3
2.39
18.4
Nontoxic, cystic
43
19
3
24.7
0.5
4
1.52
11.3
Nontoxic, solid
30
20
2
10.1
0
3
2.76
15.4
Nontoxic, solid
32
16
1
8.9
0
2
0.97
13.7
Nontoxic, solid
35
17
3
13.5
2.1
3
1.62
17.0
Nontoxic, solid
37
17
1
21.9
0
4
2.11
20.2
Toxic
20
16
1
13.8
2.9
3
0
43.9
Toxic
31
15
0
8.04
2.8
3
02
29.8
Toxic
39
13
0
4.32
0.7
2
2.912
8.05
Mean ± SD
32 6,86
1.84 1.14
15.3 8.0
2.92 0.64
1.663 0.89
15.23 2.67
Degree of compression: 0: none; 1: occasionally in supine position; 2: continuous in supine position; 3: even in upstanding position. 2On propylthiouracil therapy. 3The mean TSH and FT4 values were calculated only in nontoxic nodules.
